{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T22:14:56Z","timestamp":1769379296136,"version":"3.49.0"},"reference-count":150,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2011,8,1]],"date-time":"2011-08-01T00:00:00Z","timestamp":1312156800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurosci. Bull."],"published-print":{"date-parts":[[2011,8]]},"DOI":"10.1007\/s12264-011-1008-6","type":"journal-article","created":{"date-parts":[[2011,8,4]],"date-time":"2011-08-04T14:34:36Z","timestamp":1312468476000},"page":"275-285","source":"Crossref","is-referenced-by-count":18,"title":["Cannabinoid as a neuroprotective strategy in perinatal hypoxic-ischemic injury","\u5927\u9ebb\u7d20\u5728\u56f4\u4ea7\u671f\u7f3a\u8840\u7f3a\u6c27\u6027\u8111\u635f\u4f24\u7684\u4fdd\u62a4\u4f5c\u7528"],"prefix":"10.1007","volume":"27","author":[{"given":"Daniel","family":"Alonso-Alconada","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antonia","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Enrique","family":"Hilario","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,8,5]]},"reference":[{"key":"1008_CR1","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1515\/JPM.2000.034","volume":"28","author":"R. Berger","year":"2000","unstructured":"Berger R, Garnier Y. Perinatal brain injury. J Perinat Med 2000, 28: 261\u2013285.","journal-title":"J Perinat Med"},{"key":"1008_CR2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/1098-2779(200102)7:1<56::AID-MRDD1008>3.0.CO;2-A","volume":"7","author":"J. Volpe","year":"2001","unstructured":"Volpe J. Perinatal brain injury: from pathogenesis to neuroprotection. Mental Retard Dev Disabil Res 2001, 7: 56\u201364.","journal-title":"Mental Retard Dev Disabil Res"},{"key":"1008_CR3","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1447-0756.2004.00194.x","volume":"30","author":"J.A. Low","year":"2004","unstructured":"Low JA. Determining the contribution of asphyxia to brain damage in the neonate. J Obstet Gynaecol Res 2004, 30: 276\u2013286.","journal-title":"J Obstet Gynaecol Res"},{"key":"1008_CR4","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1242\/jeb.01064","volume":"207","author":"S. Vannuci","year":"2004","unstructured":"Vannuci S, Hagberg H. Hypoxia-ischemia in the immature brain. J Exp Biol 2004, 207: 3149\u20133154.","journal-title":"J Exp Biol"},{"key":"1008_CR5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1467-7687.2006.00499.x","volume":"9","author":"M. Hann de","year":"2006","unstructured":"de Hann M, Wyatt JS, Roth S, Vargha-Khadem F, Gadian D, Mishki M. Brain and cognitive-behavioural development after asphyxia at term birth. Dev Sci 2006, 9: 350\u2013358.","journal-title":"Dev Sci"},{"key":"1008_CR6","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/S0022-3476(05)81615-4","volume":"116","author":"C.P. Torfs","year":"1990","unstructured":"Torfs CP, van den Berg B, Oechsli FW, Cummins S. Prenatal and perinatal factors in the etiology of cerebral palsy. J Pediatr 1990, 116: 615\u2013619.","journal-title":"J Pediatr"},{"key":"1008_CR7","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/02699050110074178","volume":"15","author":"C. Ma\u00f1eru","year":"2001","unstructured":"Ma\u00f1eru C, Junque C, Botet F, Tallada M, Guardia J. Neuropsychological long-term sequelae of perinatal asphyxia. Brain Int 2001, 15: 1029\u20131039.","journal-title":"Brain Int"},{"key":"1008_CR8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.pediatrneurol.2008.12.002","volume":"40","author":"J.Y. Yager","year":"2009","unstructured":"Yager JY, Armstrong EA, Black AM. Treatment of the term newborn with brain injury: simplicity as the mother of invention. Pediatr Neurol 2009, 40: 237\u2013243.","journal-title":"Pediatr Neurol"},{"key":"1008_CR9","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0095-5108(18)30161-1","volume":"24","author":"M.J. Rivkin","year":"1997","unstructured":"Rivkin MJ. Hypoxic-ischemic brain injury in the term newborn: neuropathology, clinical aspects, and neuroimaging. Clin Perinatol 1997, 24: 607\u2013626.","journal-title":"Clin Perinatol"},{"key":"1008_CR10","first-page":"314","volume-title":"Neurology of the Newborn","author":"J.J. Volpe","year":"1995","unstructured":"Volpe JJ. Hypoxic-ischemic encephalopathy. Clinical aspects. In: Volpe JJ (ed). Neurology of the Newborn. Philadelphia: WB Saunders Co, 1995: 314\u2013369."},{"key":"1008_CR11","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/00005072-199411000-00005","volume":"53","author":"Y. Nakaruma","year":"1994","unstructured":"Nakaruma Y, Okureda T, Hashimoto T. Vascular architecture in white matter of neonates: its relationship to periventricular leukomalacia. J Neuropathol Exp Neurol 1994, 53: 582\u2013589.","journal-title":"J Neuropathol Exp Neurol"},{"key":"1008_CR12","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1071-9091(98)80030-2","volume":"5","author":"J.J. Volpe","year":"1998","unstructured":"Volpe JJ. Brain injury in the premature infant: overview of clinical aspects, neuropathology, and pathogenesis. Semin Pediatr Neurol 1998, 5: 135\u2013151.","journal-title":"Semin Pediatr Neurol"},{"key":"1008_CR13","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/S0095-5108(18)30021-6","volume":"26","author":"M. Pourcyrous","year":"1999","unstructured":"Pourcyrous M. Cerebral hemodynamic measurements in acute versus chronic asphyxia. Clin Perinatol 1999, 26: 811\u2013828.","journal-title":"Clin Perinatol"},{"key":"1008_CR14","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1523\/JNEUROSCI.21-04-01302.2001","volume":"21","author":"S.A. Back","year":"2001","unstructured":"Back SA, Luo NL, Borenstein NS, Levine JM, Volpe JJ, Kinney HC. Late oligodendrocyte progenitors coincide with the development window of vulnerability for human perinatal white matter injury. J Neurosci 2001, 21: 1302\u20131312.","journal-title":"J Neurosci"},{"key":"1008_CR15","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1080\/08035250510031151","volume":"94","author":"E. Hilario","year":"2005","unstructured":"Hilario E, Rey-Santano MC, Go\u00f1i-de-Cerio F, Alvarez FJ, Gastiasoro E, Mielgo VE, et al. Cerebral blood flow and morphological changes after hypoxic-ischaemic injury in preterm lambs. Acta Paediatr 2005, 94: 903\u2013911.","journal-title":"Acta Paediatr"},{"key":"1008_CR16","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1542\/peds.111.2.351","volume":"111","author":"L.F. Shalak","year":"2003","unstructured":"Shalak LF, Laptook AR, Velaphi SC, Perlman JM. Amplitude-integrated electroencephalography coupled with an early neurologic examination enhances prediction of term infants at risk for persistent encephalopathy. Pediatrics 2003, 111: 351\u2013357.","journal-title":"Pediatrics"},{"key":"1008_CR17","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/ALN.0b013e3181dc1b84","volume":"113","author":"R.D. Sanders","year":"2010","unstructured":"Sanders RD, Manning HJ, Robertson NJ, Ma D, Edwards AD, Hagberg H, et al. Preconditioning and postinsult therapies for perinatal hypoxic-ischemic injury at term. Anesthesiology 2010, 113: 233\u2013249.","journal-title":"Anesthesiology"},{"key":"1008_CR18","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1542\/peds.97.4.456","volume":"97","author":"J.M. Perlman","year":"1996","unstructured":"Perlman JM, Risser R. Can asphyxiated infants at risk for neonatal seizures be rapidly identified by current high-risk markers? Pediatrics 1996, 97: 456\u2013462.","journal-title":"Pediatrics"},{"key":"1008_CR19","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S0165-0173(98)00053-8","volume":"29","author":"M. Walton","year":"1999","unstructured":"Walton M, Connor B, Lawlor P, Young D, Sirimanne E, Gluckman P, et al. Neuronal death and survival in two models of hypoxic-ischemic brain damage. Brain Res Rev 1999, 29: 137\u2013168.","journal-title":"Brain Res Rev"},{"key":"1008_CR20","doi-asserted-by":"crossref","first-page":"1985","DOI":"10.1056\/NEJMra041996","volume":"351","author":"D.M. Ferriero","year":"2004","unstructured":"Ferriero DM. Neonatal brain injury. N Engl J Med 2004, 351: 1985\u20131995.","journal-title":"N Engl J Med"},{"key":"1008_CR21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1602\/neurorx.1.1.17","volume":"1","author":"T. Sugawara","year":"2004","unstructured":"Sugawara T, Fujimura M, Noshita N, Kim GW, Saito A, Hayashi T, et al. Neuronal death\/survival signaling pathways in cerebral ischemia. NeuroRx 2004, 1: 17\u201325.","journal-title":"NeuroRx"},{"key":"1008_CR22","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1203\/00006450-199711000-00022","volume":"42","author":"A.D. Edwards","year":"1997","unstructured":"Edwards AD, Yue X, Cox P, Hope PL, Azzopardi DV, Squier MV, et al. Apoptosis in the brains of infants suffering intrauterine cerebral injury. Pediatr Res 1997, 42: 684\u2013689.","journal-title":"Pediatr Res"},{"key":"1008_CR23","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/j.1365-2990.1997.tb01181.x","volume":"23","author":"X. Yue","year":"1997","unstructured":"Yue X, Mehmet H, Penrice J, Cooper C, Cady EB, Wyatt JS, et al. Apoptosis and necrosis in the newborn piglet brain following transient HI. Neuropathol Appl Neurobiol 1997, 23: 16\u201325.","journal-title":"Neuropathol Appl Neurobiol"},{"key":"1008_CR24","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1096\/fasebj.13.9.1055","volume":"13","author":"J.M. Esteve","year":"1999","unstructured":"Esteve JM, Mompo J, Garc\u00eda de la Asunci\u00f3n J, Satre J, Asensi M, Boix J, et al. Oxidative damage to mitochondrial DNA and glutathione oxidation in apoptosis studies in vivo and in vitro. FASEB J 1999, 13: 1055\u20131064.","journal-title":"FASEB J"},{"key":"1008_CR25","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1750-3639.1999.tb00213.x","volume":"9","author":"D.L. Taylor","year":"1999","unstructured":"Taylor DL, Edwards AD, Mehmet H. Oxidative metabolism, apoptosis and perinatal brain injury. Brain Pathol 1999, 9: 93\u2013117.","journal-title":"Brain Pathol"},{"key":"1008_CR26","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1203\/00006450-200007000-00007","volume":"48","author":"J. Ohyu","year":"2000","unstructured":"Ohyu J, Endo A, Itoh M, Takashima S. Hypocapnia under hypotension induces apoptotic neuronal cell death in the hippocampus of newborn rabbits. Pediatric Res 2000, 48: 24\u201329.","journal-title":"Pediatric Res"},{"key":"1008_CR27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/157339606776894667","volume":"2","author":"E. Hilario","year":"2006","unstructured":"Hilario E, Alvarez A, Alvarez FJ, Gastiasoro E, Valls-i-Soler A. Cellular mechanisms in perinatal hypoxic-ischemic brain injury. Current Pediatr Rev 2006, 2: 131\u2013141.","journal-title":"Current Pediatr Rev"},{"key":"1008_CR28","first-page":"1025","volume-title":"Microscopy: Science, Technology, Applications and Education","author":"E. Hilario","year":"2010","unstructured":"Hilario E, Ca\u00f1avate ML, Lacalle J, Alonso-Alconada D, Lara-Celador I, Alvarez-Granda L, et al. Cell death. A comprehensive approximation. Delayed cell death. In: M\u00e9ndez-Vilas A, D\u00edaz J (eds). Microscopy: Science, Technology, Applications and Education. Badajoz: Formatex Research Centre, 2010: 1025\u20131032."},{"key":"1008_CR29","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1172\/JCI119153","volume":"99","author":"A.J. Gunn","year":"1997","unstructured":"Gunn AJ, Gunn T, de Haan H, Williams C, Gluckman P. Dramatic neuronal rescue with prolonged selective head cooling after ischemia in fetal sheep. J Clin Invest 1997, 99: 248\u2013256.","journal-title":"J Clin Invest"},{"key":"1008_CR30","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.pharmthera.2008.07.003","volume":"120","author":"F.F. Gonzalez","year":"2008","unstructured":"Gonzalez FF, Ferriero DM. Therapeutics for neonatal brain injury. Pharmacol Ther 2008, 120: 43\u201353.","journal-title":"Pharmacol Ther"},{"key":"1008_CR31","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.earlhumdev.2010.05.011","volume":"86","author":"D. Kelen","year":"2010","unstructured":"Kelen D, Robertson NJ. Experimental treatments for hypoxic ischaemic encephalopathy. Early Hum Dev 2010, 86: 369\u2013377.","journal-title":"Early Hum Dev"},{"key":"1008_CR32","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.siny.2010.02.002","volume":"15","author":"M.R. Cilio","year":"2010","unstructured":"Cilio MR, Ferriero DM. Synergistic neuroprotective therapies with hypothermia. Semin Fetal Neonatal Med 2010, 15: 293\u2013298.","journal-title":"Semin Fetal Neonatal Med"},{"key":"1008_CR33","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/j.1750-3639.2000.tb00243.x","volume":"10","author":"J. Nedelcu","year":"2000","unstructured":"Nedelcu J, Klein MA, Aguzzi A, Martin E. Resuscitative hypothermia protects the neonatal rat brain from hypoxic-ischemic injury. Brain Pathol 2000, 10: 61\u201371.","journal-title":"Brain Pathol"},{"key":"1008_CR34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.brainres.2003.09.065","volume":"995","author":"N.G. Pabello","year":"2004","unstructured":"Pabello NG, Tracy SJ, Keller RW Jr. Protective effects of brief intra- and delayed postischemic hypothermia in a transient focal ischemia model in the neonatal rat. Brain Res 2004, 995: 29\u201338.","journal-title":"Brain Res"},{"key":"1008_CR35","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1586\/14737175.7.2.155","volume":"7","author":"H. Hertog den","year":"2007","unstructured":"den Hertog H, van der Worp B, van Gemert M, Dippel D. Therapeutic hypothermia in acute ischemic stroke. Expert Rev Neurother 2007, 7: 155\u2013164.","journal-title":"Expert Rev Neurother"},{"key":"1008_CR36","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1203\/00006450-200111000-00010","volume":"50","author":"M. Adachi","year":"2001","unstructured":"Adachi M, Sohma O, Tsuneishi S, Takada S, Nakamura H. Combination effect of systemic hypothermia and cascase inhibitor administration against hypoxic-ischemic brain damage in neonatal rats. Pediatric Res 2001, 50: 590\u2013595.","journal-title":"Pediatric Res"},{"key":"1008_CR37","first-page":"83","volume":"49","author":"T. Hashimoto","year":"2003","unstructured":"Hashimoto T, Yonetani M, Nakamura H. Selective brain hypothermia protects against hypoxic-ischemic injury in newborn rats by reducing hydroxyl radical production. Kobe J Med Sci 2003, 49: 83\u201391.","journal-title":"Kobe J Med Sci"},{"key":"1008_CR38","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.brainres.2003.10.013","volume":"996","author":"C. Zhu","year":"2004","unstructured":"Zhu C, Wang X, Cheng X, Qui L, Xu F, Simbruner G, et al. Postischemic hypothermia-induced tissue protection and diminished apoptosis after neonatal cerebral hypoxia-ischemia. Brain Res 2004, 996: 67\u201375.","journal-title":"Brain Res"},{"key":"1008_CR39","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1542\/peds.2006-2839","volume":"119","author":"J.S. Wyatt","year":"2007","unstructured":"Wyatt JS, Gluckman PD, Liu PY, Azzopardi D, Ballard R, Edwards AD, et al. Determinants of outcomes after head cooling for neonatal encephalopathy. Pediatrics 2007, 119: 912\u2013921.","journal-title":"Pediatrics"},{"key":"1008_CR40","first-page":"405","volume":"33","author":"C. Palmer","year":"1993","unstructured":"Palmer C, Towfighi J, Roberts RL, Heitjan DF. Allopurinol administered after inducing damage with HI reduces brain injury in 7 days old rats. Pediatr Res 1993, 33: 405\u2013411.","journal-title":"Pediatr Res"},{"key":"1008_CR41","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1542\/peds.101.2.185","volume":"101","author":"F. Bel Van","year":"1998","unstructured":"Van Bel F, Shadid M, Moison RM, Dorrepaal CA, Fontijn J, Monteiro L, et al. Effect of allopurinol on postasphyxial free radical formation, cerebral hemodynamics, and electrical brain activity. Pediatrics 1998, 101: 185\u2013193.","journal-title":"Pediatrics"},{"key":"1008_CR42","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1523\/JNEUROSCI.15-04-02857.1995","volume":"15","author":"G. Ferrari","year":"1995","unstructured":"Ferrari G, Yan CYI, Greene LA. Acetylcysteine (D- and L- sterioisomers) prevent apoptotic death of neuronal cells. J Neurosci 1995, 15: 2857\u20132866.","journal-title":"J Neurosci"},{"key":"1008_CR43","doi-asserted-by":"crossref","first-page":"26827","DOI":"10.1074\/jbc.270.45.26827","volume":"270","author":"C.Y.I. Yan","year":"1995","unstructured":"Yan CYI, Ferrari G, Greene LA. N-Acetylcysteine promoted survival of PC12 cells is glutathione independent but transcription dependent. J Biol Chem 1995, 270: 26827\u201326832.","journal-title":"J Biol Chem"},{"key":"1008_CR44","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1203\/01.pdr.0000215045.91122.44","volume":"59","author":"M. Jatana","year":"2006","unstructured":"Jatana M, Singh I, Singh AK, Jenkins D. Combination of systemic hypothermia and N-acetylcysteine attenuates hypoxic-ischemic brain injury in neonatal rats. Pediatr Res 2006, 59: 684\u2013689.","journal-title":"Pediatr Res"},{"key":"1008_CR45","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s00134-007-0880-z","volume":"34","author":"T.F. Lee","year":"2008","unstructured":"Lee TF, Jantzie LL, Todd KG, Cheung PY. Postresuscitation Nacetylcysteine treatment reduces cerebral hydrogen peroxide in the hypoxic piglet brain. Inten Care Med 2008, 34: 190\u2013197.","journal-title":"Inten Care Med"},{"key":"1008_CR46","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1203\/01.PDR.0000159571.50758.39","volume":"57","author":"A. Sola","year":"2005","unstructured":"Sola A, Wen TC, Hamrick SE, Ferriero DM. Potential for protection and repair following injury to the developing brain: a role for erythropoietin. Pediatr Res 2005, 57: 110\u2013117.","journal-title":"Pediatr Res"},{"key":"1008_CR47","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1203\/01.PDR.0000163616.89767.69","volume":"58","author":"Y.S. Chang","year":"2005","unstructured":"Chang YS, Mu D, Wendland M, Sheldon RA, Vexler ZS, McQuillen PS, et al. Erythropoietin improves functional and histological outcome in neonatal stroke. Pediatr Res 2005, 58: 106\u2013111.","journal-title":"Pediatr Res"},{"key":"1008_CR48","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000105473","volume":"29","author":"F.F. Gonzalez","year":"2007","unstructured":"Gonzalez FF, McQuillen P, Mu D, Chang Y, Wendland M, Vexler Z, et al. Erythropoietin enhances long-term neuroprotection and neurogenesis in neonatal stroke. Dev Neurosci 2007, 29: 321\u2013330.","journal-title":"Dev Neurosci"},{"key":"1008_CR49","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1600-079X.2007.00503.x","volume":"44","author":"S. Carloni","year":"2008","unstructured":"Carloni S, Perrone S, Buonocore G, Longini M, Proietti F, Balduini W. Melatonin protects from the long-term consequences of a neonatal hypoxic-ischemic brain injury in rats. J Pineal Res 2008, 44: 157\u2013164.","journal-title":"J Pineal Res"},{"key":"1008_CR50","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1600-079X.2008.00639.x","volume":"46","author":"C. Signorini","year":"2009","unstructured":"Signorini C, Ciccoli L, Leoncini S, Carloni S, Perrone S, Comporti M, et al. Free iron, total F-isoprostanes and total F-neuroprostanes in a model of neonatal hypoxic-ischemic encephalopathy: neuroprotective effect of melatonin. J Pineal Res 2009, 46: 148\u2013154.","journal-title":"J Pineal Res"},{"key":"1008_CR51","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/ana.10242","volume":"52","author":"K.L. Arvin","year":"2002","unstructured":"Arvin KL, Han BH, Du Y, Lin SZ, Paul SM, Holtzman DM. Minocycline markedly protects the neonatal brain against hypoxicischemic injury. Ann Neurol 2002, 52: 54\u201361.","journal-title":"Ann Neurol"},{"key":"1008_CR52","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1038\/sj.jcbfm.9600025","volume":"25","author":"L.L. Jantzie","year":"2005","unstructured":"Jantzie LL, Cheung PY, Todd KG. Doxycycline reduces cleaved caspase-3 and microglial activation in an animal model of neonatal hypoxia-ischemia. J Cereb Blood Flow Metab 2005, 25: 314\u2013325.","journal-title":"J Cereb Blood Flow Metab"},{"key":"1008_CR53","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.nbd.2005.06.014","volume":"21","author":"S. Carloni","year":"2006","unstructured":"Carloni S, Mazzoni E, Cimino M, De Simoni MG, Perego C, Scopa C, et al. Simvastatin reduces caspase-3 activation and inflammatory markers induced by hypoxia-ischemia in the newborn rat. Neurobiol Dis 2006, 21: 119\u2013126.","journal-title":"Neurobiol Dis"},{"key":"1008_CR54","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.expneurol.2009.07.026","volume":"220","author":"S. Carloni","year":"2009","unstructured":"Carloni S, Girelli S, Buonocore G, Longini M, Balduini W. Simvastatin acutely reduces ischemic brain damage in the immature rat via Akt and CREB activation. Exp Neurol 2009, 220: 82\u201389.","journal-title":"Exp Neurol"},{"key":"1008_CR55","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1038\/nrn1247","volume":"4","author":"D. Piomelli","year":"2003","unstructured":"Piomelli D. The molecular logic of endocannabinoid signalling. Nat Rev Neurosci 2003, 4: 873\u2013884.","journal-title":"Nat Rev Neurosci"},{"key":"1008_CR56","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.chembiol.2007.05.014","volume":"14","author":"V. Marzo Di","year":"2007","unstructured":"Di Marzo V, Bisogno T, De Petrocellis L. Endocannabinoids and related compounds: walking back and forth between plant natural products and animal physiology. Chem Biol 2007, 14: 741\u2013756.","journal-title":"Chem Biol"},{"key":"1008_CR57","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1021\/cr0782067","volume":"108","author":"K. Ahn","year":"2008","unstructured":"Ahn K, McKinney MK, Cravatt BF. Enzymatic pathways that regulate endocannabinoid signaling in the nervous system. Chem Rev 2008, 108: 1687\u20131707.","journal-title":"Chem Rev"},{"key":"1008_CR58","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.neuropharm.2004.07.030","volume":"247","author":"A.C. Howlett","year":"2004","unstructured":"Howlett AC, Breivogel CS, Childers SR, Deadwyler SA, Hampson RE, Porrino LJ. Cannabinoid physiology and pharmacology: 30 years of progress. Neuropharmacology 2004, 247: 345\u2013358.","journal-title":"Neuropharmacology"},{"key":"1008_CR59","doi-asserted-by":"crossref","first-page":"23278","DOI":"10.1074\/jbc.M201084200","volume":"277","author":"K.R. Kozak","year":"2002","unstructured":"Kozak KR, Gupta RA, Moody JS, Ji C, Boeglin WE, DuBois RN, et al. Lipoxygenase metabolism of 2-arachidonylglycerol. Generation of a peroxisome proliferator-activated receptor alpha agonist. J Biol Chem 2002, 277: 23278\u201323286.","journal-title":"J Biol Chem"},{"key":"1008_CR60","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1038\/sj.bjp.0704223","volume":"134","author":"S.J. Craib","year":"2001","unstructured":"Craib SJ, Ellington HC, Pertwee RG, Ross RA. A possible role of lipoxygenase in the activation of vanilloid receptors by anandamide in the guinea-pig bronchus. Br J Pharmacol 2001, 134: 30\u201337.","journal-title":"Br J Pharmacol"},{"key":"1008_CR61","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/j.1432-1033.1995.tb20780.x","volume":"232","author":"S. Gali\u00e8gue","year":"1995","unstructured":"Gali\u00e8gue S, Mary S, Marchand J, Dussossoy D, Carri\u00e8re D, Carayon P, et al. Expression of central and peripheral cannabinoid receptors in human immune tissues and leukocyte subpopulations. Eur J Biochem 1995, 232: 54\u201361.","journal-title":"Eur J Biochem"},{"key":"1008_CR62","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/syn.20050","volume":"53","author":"E. N\u00fa\u00f1ez","year":"2004","unstructured":"N\u00fa\u00f1ez E, Benito C, Pazos MR, Barbachano A, Fajardo O, Gonz\u00e1lez S, et al. Cannabinoid CB2 receptors are expressed by perivascular microglial cells in the human brain: an immunohistochemical study. Synapse 2004, 53: 208\u2013213.","journal-title":"Synapse"},{"key":"1008_CR63","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1126\/science.1115740","volume":"310","author":"M.D. Sickle Van","year":"2005","unstructured":"Van Sickle MD, Duncan M, Kingsley PJ, Mouihate A, Urbani P, Mackie K, et al. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 2005, 310: 329\u2013332.","journal-title":"Science"},{"key":"1008_CR64","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1196\/annals.1369.052","volume":"1074","author":"E.S. Onaivi","year":"2006","unstructured":"Onaivi ES, Ishiguro H, Gong JP, Patel S, Perchuk A, Meozzi PA, et al. Discovery of the presence and functional expression of cannabinoid CB2 receptors in brain. Ann N Y Acad Sci 2006, 1074: 514\u2013536.","journal-title":"Ann N Y Acad Sci"},{"key":"1008_CR65","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.brainres.2005.11.035","volume":"1071","author":"J.P. Gong","year":"2006","unstructured":"Gong JP, Onaivi ES, Ishiguro H, Liu QR, Tagliaferro PA, Brusco A, et al. Cannabinoid CB2 receptors: immunohistochemical localization in rat brain. Brain Res 2006, 1071: 10\u201323.","journal-title":"Brain Res"},{"key":"1008_CR66","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/S0031-6997(25)06864-4","volume":"38","author":"W.L. Dewey","year":"1986","unstructured":"Dewey WL. Cannabinoid Pharmacology. Pharmacol Rev 1986, 38: 151\u2013178.","journal-title":"Pharmacol Rev"},{"key":"1008_CR67","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1124\/pr.54.2.161","volume":"54","author":"A.C. Howlett","year":"2002","unstructured":"Howlett AC, Barth F, Bonner TI, Cabral G, Casellas P, Devane WA, et al. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol Rev 2002, 54: 161\u2013202.","journal-title":"Pharmacol Rev"},{"key":"1008_CR68","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","volume":"258","author":"W.A. Devane","year":"1992","unstructured":"Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, et al. Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 1992, 258: 1946\u20131949.","journal-title":"Science"},{"key":"1008_CR69","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/0006-2952(95)00109-D","volume":"50","author":"R. Mechoulam","year":"1995","unstructured":"Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR, et al. Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 1995, 50: 83\u201390.","journal-title":"Biochem Pharmacol"},{"key":"1008_CR70","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1006\/bbrc.1995.2437","volume":"215","author":"T. Sugiura","year":"1995","unstructured":"Sugiura T, Kondo S, Sukagawa A, Nakane S, Shinoda A, Itoh K, et al. 2-Arachidonoylglycerol: a possible endogenous cannabinoid receptor ligand in brain. Biochem Biophys Res Commun 1995, 215: 89\u201397.","journal-title":"Biochem Biophys Res Commun"},{"key":"1008_CR71","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/sj.ijo.0803273","volume":"30","author":"K. Mackie","year":"2006","unstructured":"Mackie K. Mechanisms of CB1 receptor signalling: endocannabinoid modulation of synaptic strength. Int J Obesity 2006, 30: 19\u201323.","journal-title":"Int J Obesity"},{"key":"1008_CR72","doi-asserted-by":"crossref","first-page":"3662","DOI":"10.1073\/pnas.061029898","volume":"98","author":"L. Hanus","year":"2001","unstructured":"Hanus L, Abu-Lafi S, Fride E, Breuer A, Vogel Z, Shalev DE, et al. 2-Arachidonyl glyceryl ether, an endogenous agonist of the cannabinoid CB1 receptor. Proc Natl Acad Sci U S A 2001, 98: 3662\u20133665.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1008_CR73","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1124\/jpet.301.3.1020","volume":"301","author":"A.C. Porter","year":"2002","unstructured":"Porter AC, Sauer JM, Knierman MD, Becker GW, Berna MJ, Bao J, et al. Characterization of a novel endocannabinoid, virodhamine, with antagonist activity at the CB1 receptor. J Pharmacol Exp Ther 2002, 301: 1020\u20131024.","journal-title":"J Pharmacol Exp Ther"},{"key":"1008_CR74","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1042\/0264-6021:3510817","volume":"3","author":"T. Bisogno","year":"2000","unstructured":"Bisogno T, Melck D, Bobrov MY, Gretskaya NM, Bezuglov VV, De Petrocellis L, et al. N-acyl-dopamines: novel synthetic CB(1) cannabinoid-receptor ligands and inhibitors of anandamide inactivation with cannabimimetic activity in vitro and in vivo. Biochem J 2000, 3: 817\u2013824.","journal-title":"Biochem J"},{"key":"1008_CR75","doi-asserted-by":"crossref","first-page":"8400","DOI":"10.1073\/pnas.122196999","volume":"99","author":"S.M. Huang","year":"2002","unstructured":"Huang SM, Bisogno T, Trevisani M, Al-Hayani A, De Petrocellis L, Fezza F, et al. An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci U S A 2002, 99: 8400\u20138405.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1008_CR76","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/0014-5793(94)00773-X","volume":"350","author":"M. Rinaldi-Carmona","year":"1994","unstructured":"Rinaldi-Carmona M, Barth F, H\u00e9aulme M, Shire D, Calandra B, Martinez S, et al. SR141716A, a potent and selective antagonist of the brain cannabinoid receptor. FEBS Lett 1994, 350: 240\u2013244.","journal-title":"FEBS Lett"},{"key":"1008_CR77","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/S0022-3565(24)37266-0","volume":"284","author":"M. Rinaldi-Carmona","year":"1998","unstructured":"Rinaldi-Carmona M, Barth F, Millan J, Derocq JM, Casellas P, Congy C, et al. SR 144528, the first potent and selective antagonist of the CB2 cannabinoid receptor. J Pharmacol Exp Ther 1998, 284: 644\u2013650.","journal-title":"J Pharmacol Exp Ther"},{"key":"1008_CR78","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0026-895X(25)09876-1","volume":"34","author":"W.A. Devane","year":"1988","unstructured":"Devane WA, Dysarz FA, Johnson MR, Melvin LS, Howlett AC. Determination and characterization of a cannabinoid receptor in rat brain. Mol Pharmacol 1988, 34: 605\u2013613.","journal-title":"Mol Pharmacol"},{"key":"1008_CR79","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1021\/jm00107a034","volume":"34","author":"M.R. Bell","year":"1991","unstructured":"Bell MR, D\u2019Ambra TE, Kumar V, Eissenstat MA, Herrman JL. Antinociceptive (aminoalkyl)-indoles. J Med Chem 1991, 34: 1099\u20131110.","journal-title":"J Med Chem"},{"key":"1008_CR80","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/0006-8993(92)90428-C","volume":"575","author":"E.M. Jansen","year":"1992","unstructured":"Jansen EM, Haycock DA, Ward SJ, Seybold VS. Distribution of cannabinoid receptors in rat brain determined with aminoalkylindoles. Brain Res 1992, 575: 93\u2013102.","journal-title":"Brain Res"},{"key":"1008_CR81","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1016\/S0022-3565(25)10152-3","volume":"264","author":"J.E. Kuster","year":"1993","unstructured":"Kuster JE, Stevenson JI, Ward SJ, D\u2019Ambra TE, Haycock DA. Aminoalkylindole binding in rat cerebellum: selective displacement by natural and synthetic cannabinoids. J Pharmacol Exp Ther 1993, 264: 1352\u20131363.","journal-title":"J Pharmacol Exp Ther"},{"key":"1008_CR82","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/372686a0","volume":"372","author":"V. Marzo Di","year":"1994","unstructured":"Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, et al. Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 1994, 372: 686\u2013691.","journal-title":"Nature"},{"key":"1008_CR83","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/neu.20080","volume":"61","author":"B.F. Cravatt","year":"2004","unstructured":"Cravatt BF, Lichtman AH. The endogenous cannabinoid system and its role in nociceptive behavior. J Neurobiol 2004, 61: 149\u2013160.","journal-title":"J Neurobiol"},{"key":"1008_CR84","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0090-6980(02)00053-9","volume":"68\u201369","author":"N. Ueda","year":"2002","unstructured":"Ueda N. Endocannabinoid hydrolases. Prostaglandins Other Lipid Mediat 2002, 68\u201369: 521\u2013534.","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"1008_CR85","doi-asserted-by":"crossref","first-page":"35552","DOI":"10.1074\/jbc.M106261200","volume":"276","author":"N. Ueda","year":"2001","unstructured":"Ueda N, Yamanaka K, Yamamoto S. Purification and characterization of an acid amidase selective for N-palmitoylethanolamine, a putative endogenous anti-inflammatory substance. J Biol Chem 2001, 276: 35552\u201335557.","journal-title":"J Biol Chem"},{"key":"1008_CR86","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1007\/s00018-004-4494-0","volume":"62","author":"J. Verme Lo","year":"2005","unstructured":"Lo Verme J, Gaetani S, Fu J, Oveisi F, Burton K, Piomelli D. Regulation of food intake by oleoylethanolamide. Cell Mol Life Sci 2005, 62: 708\u2013716.","journal-title":"Cell Mol Life Sci"},{"key":"1008_CR87","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1054\/plef.2001.0359","volume":"66","author":"K.R. Kozak","year":"2002","unstructured":"Kozak KR, Marnett LJ. Oxidative metabolism of endocannabinoids. Prostaglandins Leukot Essent Fatty Acids 2002, 66: 211\u2013220.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"key":"1008_CR88","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1016\/j.bcp.2003.12.003","volume":"67","author":"S.M. Saario","year":"2004","unstructured":"Saario SM, Savinainen JR, Laitinen JT, J\u00e4rvinen T, Niemi R. Monoglyceride lipase-like enzymatic activity is responsible for hydrolysis of 2-arachidonoylglycerol in rat cerebellar membranes. Biochem Pharmacol 2004, 67: 1381\u20131387.","journal-title":"Biochem Pharmacol"},{"key":"1008_CR89","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1124\/mol.104.002071","volume":"66","author":"T.P. Dinh","year":"2004","unstructured":"Dinh TP, Kathuria S, Piomelli D. RNA interference suggests a primary role for monoacylglycerol lipase in the degradation of the endocannabinoid 2-arachidonoylglycerol. Mol Pharmacol 2004, 66: 1260\u20131264.","journal-title":"Mol Pharmacol"},{"key":"1008_CR90","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0009-3084(00)00197-3","volume":"108","author":"B.C. Paria","year":"2000","unstructured":"Paria BC, Dey SK. Ligand-receptor signaling with endocannabinoids in preimplantation embryo development and implantation. Chem Phys Lipids 2000, 108: 211\u2013220.","journal-title":"Chem Phys Lipids"},{"key":"1008_CR91","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S0166-2236(99)01491-5","volume":"23","author":"J. Fernandez-Ruiz","year":"2000","unstructured":"Fernandez-Ruiz J, Berrendero F, Hernandez ML, Ramos JA. The endogenous cannabinoid system and brain development. Trends Neurosci 2000, 23: 14\u201320.","journal-title":"Trends Neurosci"},{"key":"1008_CR92","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/(SICI)1098-2396(19990901)33:3<181::AID-SYN3>3.0.CO;2-R","volume":"33","author":"F. Berrendero","year":"1999","unstructured":"Berrendero F, Sepe N, Ramos JA, Di Marzo V, Fern\u00e1ndez-Ruiz JJ. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse 1999, 33: 181\u2013191.","journal-title":"Synapse"},{"key":"1008_CR93","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/(SICI)1098-2396(199707)26:3<317::AID-SYN12>3.0.CO;2-S","volume":"26","author":"J. Romero","year":"1997","unstructured":"Romero J, Garcia-Palomero E, Berrendero F, Garcia-Gil L, Hern\u00e1ndez ML, Ramos JA, et al. Atypical localization of cannabinoid receptors in white matter areas during rat brain development. Synapse 1997, 26: 317\u2013323.","journal-title":"Synapse"},{"key":"1008_CR94","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1006\/nimg.2001.0939","volume":"14","author":"A. Biegon","year":"2001","unstructured":"Biegon A, Kerman IA. Autoradiographic study of pre- and postnatal distribution of cannabinoid receptors in human brain. Neuroimage 2001, 14: 1463\u20131468.","journal-title":"Neuroimage"},{"key":"1008_CR95","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1046\/j.1460-9568.2003.02599.x","volume":"17","author":"S. Mato","year":"2003","unstructured":"Mato S, Del Olmo E, Pazos A. Ontogenetic development of cannabinoid receptor expression and signal transduction functionality in the human brain. Eur J Neurosci 2003, 17: 1747\u20131754.","journal-title":"Eur J Neurosci"},{"key":"1008_CR96","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1126\/science.1063545","volume":"296","author":"R.I. Wilson","year":"2002","unstructured":"Wilson RI, Nicoll RA. Endocannabinoid signaling in the brain. Science 2002, 296: 678\u2013682.","journal-title":"Science"},{"key":"1008_CR97","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1016\/S0896-6273(01)00247-1","volume":"29","author":"T. Ohno-Shosaku","year":"2001","unstructured":"Ohno-Shosaku T, Maejima T, Kano M. Endogenous cannabinoids mediate retrograde signals from depolarized postsynaptic neurons to presynaptic terminals. Neuron 2001, 29: 729\u2013738.","journal-title":"Neuron"},{"key":"1008_CR98","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1196\/annals.1367.024","volume":"1083","author":"I. Kyrou","year":"2006","unstructured":"Kyrou I, Valsamakis G, Tsigos C. The endocannabinoid system as a target for the treatment of visceral obesity and metabolic syndrome. Ann N Y Acad Sci 2006, 1083: 270\u2013305.","journal-title":"Ann N Y Acad Sci"},{"key":"1008_CR99","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/S0166-2236(98)01283-1","volume":"21","author":"V. Marzo Di","year":"1998","unstructured":"Di Marzo V, Melck D, Bisogno T, De Petrocellis L. Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci 1998, 21: 521\u2013528.","journal-title":"Trends Neurosci"},{"key":"1008_CR100","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/S0896-6273(01)00375-0","volume":"31","author":"T. Maejima","year":"2001","unstructured":"Maejima T, Hashimoto K, Yoshida T, Aiba A, Kano M. Presynaptic inhibition caused by retrograde signal from metabotropic glutamate to cannabinoid receptors. Neuron 2001, 31: 463\u2013475.","journal-title":"Neuron"},{"key":"1008_CR101","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.2174\/138161208785740117","volume":"14","author":"I. Galve-Roperh","year":"2008","unstructured":"Galve-Roperh I, Aguado T, Palazuelos J, Guzm\u00e1n M. Mechanisms of control of neuron survival by the endocannabinoid system. Curr Pharm Des 2008, 14: 2279\u20132288.","journal-title":"Curr Pharm Des"},{"key":"1008_CR102","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1152\/jn.2001.85.1.468","volume":"85","author":"G. Gerdeman","year":"2001","unstructured":"Gerdeman G, Lovinger DM. CB1 cannabinoid receptor inhibits synaptic release of glutamate in rat dorsolateral striatum. J Neurophysiol 2001, 85: 468\u2013471.","journal-title":"J Neurophysiol"},{"key":"1008_CR103","doi-asserted-by":"crossref","first-page":"4865","DOI":"10.1523\/JNEUROSCI.0403-04.2004","volume":"24","author":"M. Galante","year":"2004","unstructured":"Galante M, Diana MA. Group I metabotropic glutamate receptors inhibit GABA release atinterneuron-Purkinje cell synapses through endocannabinoid production. J Neurosci 2004, 24: 4865\u20134874.","journal-title":"J Neurosci"},{"key":"1008_CR104","doi-asserted-by":"crossref","first-page":"5794","DOI":"10.1523\/JNEUROSCI.0372-06.2006","volume":"26","author":"M.R. Domenici","year":"2006","unstructured":"Domenici MR, Azad SC, Marsicano G, Schierloh A, Wotjak CT, Dodt HU, et al. Cannabinoid receptor type 1 located on presynaptic terminals of principal neurons in the forebrain controls glutamatergic synaptic transmission. J Neurosci 2006, 26: 5794\u20135799.","journal-title":"J Neurosci"},{"key":"1008_CR105","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.neuropharm.2007.07.003","volume":"54","author":"B. Nemeth","year":"2008","unstructured":"Nemeth B, Ledent C, Freund TF, Hajos N. CB1 receptor-dependent and -independent inhibition of excitatory postsynaptic currents in the hippocampus by WIN 55,212-2. Neuropharmacology 2008, 54: 51\u201357.","journal-title":"Neuropharmacology"},{"key":"1008_CR106","doi-asserted-by":"crossref","first-page":"7162","DOI":"10.1073\/pnas.92.16.7162","volume":"92","author":"E. Bonfoco","year":"1995","unstructured":"Bonfoco E, Krainc D, Ankarcrona M, Nicotera P, Lipton SA. Apoptosis and necrosis: two distinct events induced, respectively, by mild and intense insults with N-methyl-d-aspartate or nitric oxide? superoxide in cortical cell cultures. Proc Natl Acad Sci U S A 1995, 92: 7162\u20137166.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"1008_CR107","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1523\/JNEUROSCI.19-11-04544.1999","volume":"19","author":"I. Katona","year":"1999","unstructured":"Katona I, Sperlagh B, Sik A, Kafalvi A, Vizi ES, Mackie K, et al. Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 1999, 19: 4544\u20134558.","journal-title":"J Neurosci"},{"key":"1008_CR108","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1046\/j.1460-9568.2000.00217.x","volume":"12","author":"N. Hajos","year":"2000","unstructured":"Hajos N, Katona I, Naiem SS, Mackie K, Ledent C, Mody I, et al. Cannabinoids inhibit hippocampal GABAergic transmission and network oscillations. Eur J Neurosci 2000, 12: 3239\u20133249.","journal-title":"Eur J Neurosci"},{"key":"1008_CR109","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/j.1742-4658.2008.06765.x","volume":"276","author":"D.E. Pellegrini-Giampietro","year":"2009","unstructured":"Pellegrini-Giampietro DE, Mannaioni G, Bagetta G. Post-ischemic brain damage: the endocannabinoid system in the mechanisms of neuronal death. FEBS J 2009, 276: 2\u201312.","journal-title":"FEBS J"},{"key":"1008_CR110","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1111\/j.1471-4159.2007.04642.x","volume":"102","author":"A. Ozaita","year":"2007","unstructured":"Ozaita A, Puighermanal E, Maldonado R. Regulation of PI3K\/Akt\/GSK-3 pathway by cannabinoids in the brain. J Neurochem 2007, 102: 1105\u20131114.","journal-title":"J Neurochem"},{"key":"1008_CR111","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1152\/physrev.00004.2003","volume":"83","author":"T.F. Freund","year":"2003","unstructured":"Freund TF, Katona I, Piomelli D. Role of endogenous cannabinoids in synaptic signalling. Physiol Rev 2003, 83: 1017\u20131066.","journal-title":"Physiol Rev"},{"key":"1008_CR112","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1124\/pr.58.3.2","volume":"58","author":"P. Pacher","year":"2006","unstructured":"Pacher P, Batkai S, Kunos G. The endocannabinoid system as an emerging target of pharmacotherapy. Pharmacol Rev 2006, 58: 389\u2013462.","journal-title":"Pharmacol Rev"},{"key":"1008_CR113","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/sj.bjp.0705667","volume":"141","author":"L. Walter","year":"2004","unstructured":"Walter L, Stella N. Cannabinoids and neuroinflammation. Br J Pharmacol 2004, 141: 775\u2013785.","journal-title":"Br J Pharmacol"},{"key":"1008_CR114","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1038\/nri1602","volume":"5","author":"T.W. Klein","year":"2005","unstructured":"Klein TW. Cannabinoid-based drugs as anti-inflammatory therapeutics. Nat Rev Immunol 2005, 5: 400\u2013411.","journal-title":"Nat Rev Immunol"},{"key":"1008_CR115","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1749-6632.2000.tb06193.x","volume":"899","author":"A.J. Hampson","year":"2000","unstructured":"Hampson AJ, Grimaldi M, Lolic M, Wink D, Rosenthal R, Axelrod J. Neuroprotective antioxidants from marijuana. Ann N Y Acad Sci 2000, 899: 274\u2013282.","journal-title":"Ann N Y Acad Sci"},{"key":"1008_CR116","doi-asserted-by":"crossref","first-page":"2987","DOI":"10.1523\/JNEUROSCI.19-08-02987.1999","volume":"19","author":"T. Nagayama","year":"1999","unstructured":"Nagayama T, Sinor AD, Simon RP, Chen J, Graham SH, Jin K, et al. Cannabinoids and neuroprotection in global and focal cerebral ischemia and in neuronal cultures. J Neurosci 1999, 19: 2987\u20132995.","journal-title":"J Neurosci"},{"key":"1008_CR117","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S0006-8993(99)02422-1","volume":"857","author":"D.F. Louw","year":"2000","unstructured":"Louw DF, Yang FW, Sutherland GR. The effect of delta-9-tetrahydrocannabinol on forebrain ischemia in rat. Brain Res 2000, 857: 183\u2013187.","journal-title":"Brain Res"},{"key":"1008_CR118","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0304-3940(00)01634-7","volume":"296","author":"D. Braida","year":"2000","unstructured":"Braida D, Pozzi M, Sala M. CP 55,940 protects against ischemiainduced electroencephalographic flattening and hyperlocomotion in Mongolian gerbils. Neurosci Lett 2000, 296: 69\u201372.","journal-title":"Neurosci Lett"},{"key":"1008_CR119","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/S0006-8993(03)03376-6","volume":"989","author":"F. Mauler","year":"2003","unstructured":"Mauler F, Hinz V, Augstein KH, Fassbender M, Horvath E. Neuroprotective and brain edema reducing efficacy of the novel cannabinoid receptor agonist BAY 38-7271. Brain Res 2003, 989: 99\u2013111.","journal-title":"Brain Res"},{"key":"1008_CR120","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1161\/01.STR.0000079817.68944.1E","volume":"34","author":"R.R. Leker","year":"2003","unstructured":"Leker RR, Gai N, Mechoulam R, Ovadia H. Drug-induced hypothermia reduces ischemic damage: effects of the cannabinoid HU-210. Stroke 2003, 34: 2000\u20132006.","journal-title":"Stroke"},{"key":"1008_CR121","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1097\/00001756-200410250-00016","volume":"15","author":"K. Hayakawa","year":"2004","unstructured":"Hayakawa K, Mishima K, Abe K, Hasebe N, Takamatsu F, Yasuda H, et al. Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism. Neuroreport 2004, 15: 2381\u20132385.","journal-title":"Neuroreport"},{"key":"1008_CR122","doi-asserted-by":"crossref","first-page":"9771","DOI":"10.1523\/JNEUROSCI.22-22-09771.2002","volume":"22","author":"S. Parmentier-Batteur","year":"2002","unstructured":"Parmentier-Batteur S, Jin K, Mao XO, Xie L, Greenberg DA. Increased severity of stroke in CB1 cannabinoid receptor knock-out mice. J Neurosci 2002, 22: 9771\u20139775.","journal-title":"J Neurosci"},{"key":"1008_CR123","doi-asserted-by":"crossref","first-page":"8765","DOI":"10.1523\/JNEUROSCI.21-22-08765.2001","volume":"21","author":"M. Stelt van der","year":"2001","unstructured":"van der Stelt M, Veldhuis WB, van Haaften GW, Fezza F, Bisogno T, Bar PR, et al. Exogenous anandamide protects rat brain against acute neuronal injury in vivo. J Neurosci 2001, 21: 8765\u20138771.","journal-title":"J Neurosci"},{"key":"1008_CR124","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.nbd.2005.11.004","volume":"22","author":"D. Panikashvili","year":"2006","unstructured":"Panikashvili D, Shein NA, Mechoulam R, Trembovler V, Kohen R, Alexandrovich A, et al. The endocannabinoid 2-AG protects the blood-brain barrier after closed head injury and inhibits mRNA expression of proinflammatory cytokines. Neurobiol Dis 2006, 22: 257\u2013264.","journal-title":"Neurobiol Dis"},{"key":"1008_CR125","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.brainres.2008.09.019","volume":"1240","author":"M. Schomacher","year":"2008","unstructured":"Schomacher M, M\u00fcller HD, Sommer C, Schwab S, Sch\u00e4bitz WR. Endocannabinoids mediate neuroprotection after transient focal cerebral ischemia. Brain Res 2008, 1240: 213\u2013220.","journal-title":"Brain Res"},{"key":"1008_CR126","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.nbd.2006.04.010","volume":"24","author":"M. Melis","year":"2006","unstructured":"Melis M, Pillolla G, Bisogno T, Minassi A, Petrosino S, Perra S, et al. Protective activation of the endocannabinoid system during ischemia in dopamine neurons. Neurobiol Dis 2006, 24: 15\u201327.","journal-title":"Neurobiol Dis"},{"key":"1008_CR127","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/sj.bjp.0707514","volume":"152","author":"A. Zani","year":"2007","unstructured":"Zani A, Braida D, Capurro V, Sala M. Delta9-tetrahydrocannabinol (THC) and AM 404 protect against cerebral ischaemia in gerbils through a mechanism involving cannabinoid and opioid receptors. Br J Pharmacol 2007, 152: 1301\u20131311.","journal-title":"Br J Pharmacol"},{"key":"1008_CR128","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1111\/j.1471-4159.2007.04892.x","volume":"103","author":"M. Degn","year":"2007","unstructured":"Degn M, Lambertsen KL, Petersen G, Meldgaard M, Artmann A, Clausen BH, et al. Changes in brain levels of N-acylethanolamines and 2-arachidonoylglycerol in focal cerebral ischemia in mice. J Neurochem 2007, 103: 1907\u20131916.","journal-title":"J Neurochem"},{"key":"1008_CR129","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0022-3565(24)38093-0","volume":"288","author":"Y. Waksman","year":"1999","unstructured":"Waksman Y, Olson JM, Carlisle SJ, Cabral GA. The central cannabinoid receptor (CB1) mediates inhibition of nitric oxide production by rat microglial cells. J Pharmacol Exp Ther 1999, 288: 1357\u20131366.","journal-title":"J Pharmacol Exp Ther"},{"key":"1008_CR130","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1525-1373.2000.22501.x","volume":"225","author":"T.W. Klein","year":"2000","unstructured":"Klein TW, Lane B, Newton CA, Friedman H. The cannabinoid system and cytokine network. Proc Soc Exp Biol Med 2000, 225: 1\u20138.","journal-title":"Proc Soc Exp Biol Med"},{"key":"1008_CR131","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1385\/MN:24:1-3:029","volume":"24","author":"R.I. Grundy","year":"2001","unstructured":"Grundy RI, Rabuffetti M, Beltramo M. Cannabinoids and neuroprotection. Mol Neurobiol 2001, 24: 29\u201351.","journal-title":"Mol Neurobiol"},{"key":"1008_CR132","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/S1471-4914(02)02276-1","volume":"8","author":"R. Mechoulam","year":"2002","unstructured":"Mechoulam R, Panikashvili D, Shohami E. Cannabinoids and brain injury: therapeutic implications. Trends Mol Med 2002, 8: 58\u201361.","journal-title":"Trends Mol Med"},{"key":"1008_CR133","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1203\/01.pdr.0000228839.00122.6c","volume":"60","author":"D. Fernandez-Lopez","year":"2006","unstructured":"Fernandez-Lopez D, Martinez-Orgado J, Nu\u00f1ez E, Romero J, Lorenzo P, Moro MA, et al. Characterization of the neuroprotective effect of the cannabinoid agonist WIN-55212 in an in vitro model of hypoxic-ischemic brain damage in newborn rats. Pediatr Res 2006, 60: 169\u2013173.","journal-title":"Pediatr Res"},{"key":"1008_CR134","doi-asserted-by":"crossref","first-page":"131","DOI":"10.2174\/157488907780832724","volume":"2","author":"J. Martinez-Orgado","year":"2007","unstructured":"Martinez-Orgado J, Fernandez-Lopez D, Lizasoain I, Romero J. The seek of neuroprotection: introducing cannabinoids. Recent Pat CNS Drug Discov 2007, 2: 131\u2013139.","journal-title":"Recent Pat CNS Drug Discov"},{"key":"1008_CR135","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.brainres.2010.09.050","volume":"1362","author":"D. Alonso-Alconada","year":"2010","unstructured":"Alonso-Alconada D, Alvarez FJ, Alvarez A, Mielgo VE, Go\u00f1i-de-Cerio F, Rey-Santano MC, et al. The cannabinoid receptor agonist WIN 55,212-2 reduces the initial cerebral damage after hypoxicischemic injury in fetal lambs. Brain Res 2010, 1362: 150\u2013159.","journal-title":"Brain Res"},{"key":"1008_CR136","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0022-510X(99)00194-X","volume":"170","author":"D. Gazzolo","year":"1999","unstructured":"Gazzolo D, Vinesi P, Bartocci M, Geloso MC, Bonacci W, Serra G, et al. Elevated S100 blood levels as an early indicator of intraventricular haemorrhage in preterm infants. Correlation with cerebral Doppler velocimetry. J Neurol Sci 1999, 170: 32\u201335.","journal-title":"J Neurol Sci"},{"key":"1008_CR137","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1111\/j.1651-2227.2001.tb03249.x","volume":"90","author":"M. Blennow","year":"2001","unstructured":"Blennow M, Savman K, Ilves P, Thoresen M, Rosengren L. Brainspecific proteins in the cerebrospinal fluid of severely asphyxiated newborn infants. Acta Paediatr 2001, 90: 1171\u20131175.","journal-title":"Acta Paediatr"},{"key":"1008_CR138","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.103.22.2694","volume":"103","author":"B.W. B\u00f6ttiger","year":"2001","unstructured":"B\u00f6ttiger BW, M\u00f6bes S, Gl\u00e4tzer R, Bauer H, Gries A, B\u00e4rtsch P, et al. Astroglial protein S-100 is an early and sensitive marker of hypoxic brain damage and outcome after cardiac arrest in humans. Circulation 2001, 103: 2694\u20132698.","journal-title":"Circulation"},{"key":"1008_CR139","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1203\/01.PDR.0000106806.75086.D3","volume":"55","author":"K. Thorngren-Jerneck","year":"2004","unstructured":"Thorngren-Jerneck K, Alling C, Herbst A, Amer-Wahlin I, Marsal K. S100 protein in serum as a prognostic marker for cerebral injury in term newborn infants with hypoxic ischemic encephalopathy. Pediatr Res 2004, 55: 406\u2013412.","journal-title":"Pediatr Res"},{"key":"1008_CR140","first-page":"1129","volume":"24","author":"F. Go\u00f1i-de-Cerio","year":"2009","unstructured":"Go\u00f1i-de-Cerio F, Alvarez A, Alvarez FJ, Rey-Santano MC, Alonso-Alconada D, Mielgo VE, et al. MgSO4 treatment preserves the ischemia-induced reduction in S-100 protein without modification of the expression of endothelial tight junction molecules. Histol Histopathol 2009, 24: 1129\u20131138.","journal-title":"Histol Histopathol"},{"key":"1008_CR141","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1203\/PDR.0b013e318123fbb8","volume":"62","author":"D. Fern\u00e1ndez-L\u00f3pez","year":"2007","unstructured":"Fern\u00e1ndez-L\u00f3pez D, Pazos MR, Tol\u00f3n RM, Moro MA, Romero J, Lizasoain I, et al. The cannabinoid agonist WIN55212 reduces brain damage in an in vivo model of hypoxic-ischemic encephalopathy in newborn rats. Pediatr Res 2007, 62: 255\u2013260.","journal-title":"Pediatr Res"},{"key":"1008_CR142","doi-asserted-by":"crossref","first-page":"2956","DOI":"10.1161\/STROKEAHA.110.599357","volume":"41","author":"D. Fern\u00e1ndez-L\u00f3pez","year":"2010","unstructured":"Fern\u00e1ndez-L\u00f3pez D, Pradillo JM, Garc\u00eda-Y\u00e9benes I, Mart\u00ednez-Orgado JA, Moro MA, Lizasoain I. The cannabinoid WIN55212-2 promotes neural repair after neonatal hypoxia-ischemia. Stroke 2010, 41: 2956\u20132964.","journal-title":"Stroke"},{"key":"1008_CR143","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.tips.2006.11.001","volume":"28","author":"J. Fern\u00e1ndez-Ruiz","year":"2007","unstructured":"Fern\u00e1ndez-Ruiz J, Romero J, Velasco G, Tolon RM, Ramos JA, Guzman M. Cannabinoid CB2 receptor: a new target for controlling neural cell survival? Trends Pharmacol Sci 2007, 28: 39\u201345.","journal-title":"Trends Pharmacol Sci"},{"key":"1008_CR144","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neulet.2006.10.053","volume":"412","author":"J.C. Ashton","year":"2007","unstructured":"Ashton JC, Rahman RMA, Nair SM, Sutherland BA, Glass M, Appleton I. Cerebral hypoxia-ischemia and middle cerebral artery occlusion induce expression of the cannabinoide CB2 receptor in the brain. Neurosci Lett 2007, 412: 114\u2013117.","journal-title":"Neurosci Lett"},{"key":"1008_CR145","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/j.1527-3458.2003.tb00259.x","volume":"9","author":"F. Mauler","year":"2003","unstructured":"Mauler F, Horvath E, De Vry J, Jager R, Schwarz T, Sandmann S, et al. BAY 38-7271: a novel highly selective and highly potent cannabinoid receptor agonist for the treatment of traumatic brain injury. CNS Drug Rev 2003, 9: 343\u2013358.","journal-title":"CNS Drug Rev"},{"key":"1008_CR146","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1191\/1352458504ms1009oa","volume":"10","author":"X. Ni","year":"2004","unstructured":"Ni X, Geller EB, Eppihimer MJ, Eisenstein TK, Adler MW, Tuma RF. WIN 55212-2, a cannabinoid receptor agonist, attenuates leukocyte\/endothelial interactions in an experimental autoimmune encephalomyelitis model. Mult Scler 2004, 10: 158\u2013164.","journal-title":"Mult Scler"},{"key":"1008_CR147","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1523\/JNEUROSCI.4540-04.2005","volume":"25","author":"B.G. Ramirez","year":"2005","unstructured":"Ramirez BG, Blazquez C, Gomez del Pulgar T, Guzman M, de Ceballos ML. Prevention of Alzheimer\u2019s disease pathology by cannabinoids: neuroprotection mediated by blockade of microglial activation. J Neurosci 2005, 25: 1904\u20131913.","journal-title":"J Neurosci"},{"key":"1008_CR148","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1471-4159.2005.03380.x","volume":"95","author":"K. Maresz","year":"2005","unstructured":"Maresz K, Carrier EJ, Ponomarev ED, Hillard CJ, Dittel BN. Modulation of the cannabinoid CB2 receptor in microglial cells in response to inflammatory stimuli. J Neurochem 2005, 95: 437\u2013445.","journal-title":"J Neurochem"},{"key":"1008_CR149","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.mce.2008.01.001","volume":"286","author":"J. Fern\u00e1ndez-Ruiz","year":"2008","unstructured":"Fern\u00e1ndez-Ruiz J, Pazos MR, Garcia-Arencibia M, Sagredo O, Ramos JA. Role of CB2 receptors in neuroprotective effects of cannabinoids. Mol Cell Endocrinol 2008, 286: 91\u201396.","journal-title":"Mol Cell Endocrinol"},{"key":"1008_CR150","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.nbd.2009.10.023","volume":"37","author":"A. Castillo","year":"2010","unstructured":"Castillo A, Tol\u00f3n MR, Fern\u00e1ndez-Ruiz J, Romero J, Martinez-Orgado J. The neuroprotective effect of cannabidiol in an in vitro model of newborn hypoxic-ischemic brain damage in mice is mediated by CB(2) and adenosine receptors. Neurobiol Dis 2010, 37: 434\u2013440.","journal-title":"Neurobiol Dis"}],"container-title":["Neuroscience Bulletin"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-011-1008-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12264-011-1008-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12264-011-1008-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T05:22:25Z","timestamp":1741411345000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12264-011-1008-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,8]]},"references-count":150,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2011,8]]}},"alternative-id":["1008"],"URL":"https:\/\/doi.org\/10.1007\/s12264-011-1008-6","relation":{},"ISSN":["1673-7067","1995-8218"],"issn-type":[{"value":"1673-7067","type":"print"},{"value":"1995-8218","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,8]]}}}